Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin
Agreement includes upfront, milestone and royalty payments on future sales
10-Apr-2008 -
Lorus Therapeutics Inc. announced today that its subsidiary GeneSense Technologies, Inc. has signed an exclusive multinational license agreement with Zor Pharmaceuticals LLC formed as a subsidiary of Zoticon Bioventures Inc., a research-driven biopharmaceutical group, to further develop and ...
Japan
license agreements
New Zealand
+1